Myeloproliferative neoplasms (MPN) are haematopoietic stem cell disorders characterized by uncontrolled cellular growth, with overproduction of differentiated blood cells, associated with specific somatic mutations in the JAK-STAT pathway genes [1]. The gene discussed is SOAT1; the disease is myeloproliferative neoplasm.